Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Itopride hydrochloride orally disintegrating tablets and preparation method thereof

A technology of itopride hydrochloride and orally disintegrating tablets, which can be applied in pharmaceutical formulations, medical preparations of non-active ingredients, and drug delivery, and can solve problems such as high energy consumption, inapplicability, and excessive use of excipients

Inactive Publication Date: 2018-03-13
HUAYI PHARMA ANHUI CO LTD
View PDF0 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] Common itopride hydrochloride preparations on the market are mostly capsules or tablets, but in the field of pediatrics and geriatric medicine, tablets and capsules are difficult to swallow, and the dosage form of capsules or tablets affects the compliance of drug treatment to a certain extent
Because ordinary tablets and capsules have to disintegrate in the stomach to release the drug, the onset of action is slow, and it is difficult to swallow due to their large size. It is not suitable for infants, critically ill patients and elderly patients. In the absence of water also difficult to take
Oral liquids and dispersible tablets have solved the above problems to a certain extent, but due to the characteristics of the dosage form, the preparation process is complicated, many auxiliary materials are used, energy consumption is large, and the cost is high.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Itopride hydrochloride orally disintegrating tablets and preparation method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0015] Mix 50mg of itopride hydrochloride, 110mg of mannitol, 20mg of citric acid in parts by weight, 40mg of polyvinylpyrrolidone and an appropriate amount of 50% ethanol solution and evenly add them to the above mixed material powder, mix 20mg of citric acid and stevioside in an appropriate amount to prepare Uniform soft material, passed through a 30-mesh nylon sieve to make wet granules, dried at 50-60°C for about 30 minutes, granulated through a 30-mesh sieve, mixed with 2 mg of magnesium stearate and 1 mg of micro-powdered silica gel, and pressed into tablets.

Embodiment 2

[0017] Mix 50mg of itopride hydrochloride, 110mg of mannitol, 20mg of citric acid by weight, 30mg of polyvinylpyrrolidone and an appropriate amount of 50% ethanol solution and add them into the above mixed material powder, mix 20mg of citric acid and stevioside in an appropriate amount to prepare Uniform soft material, passed through a 30-mesh nylon sieve to make wet granules, dried at 50-60°C for about 30 minutes, granulated through a 30-mesh sieve, mixed with 2 mg of magnesium stearate and 1 mg of micro-powdered silica gel, and pressed into tablets.

Embodiment 3

[0019] Mix 50mg of itopride hydrochloride, 110mg of mannitol, 20mg of citric acid in parts by weight, 20mg of polyvinylpyrrolidone and an appropriate amount of 50% ethanol solution and evenly add them to the above mixed material powder, mix 20mg of citric acid and stevioside in an appropriate amount to prepare Uniform soft material, passed through a 30-mesh nylon sieve to make wet granules, dried at 50-60°C for about 30 minutes, granulated through a 30-mesh sieve, mixed with 2 mg of magnesium stearate and 1 mg of micro-powdered silica gel, and pressed into tablets.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to the technical field of pharmaceutical preparations, in particular to an orally disintegrating itopride hydrochloride tablet and a preparation method thereof: 50 parts by weight of itopride hydrochloride, 90-110 parts by weight of mannitol, and 10-30 parts by weight of lemon Acid, 30-40 parts by weight of polyvinylpyrrolidone and an appropriate amount of 50% ethanol solution are mixed evenly and added to the above-mentioned mixed material powder, 10-30 parts by weight of citric acid and stevioside are mixed in an appropriate amount to make a uniform soft material, and passed through 30 mesh Wet granules are prepared by nylon sieve, dried at 50-60°C for about 30 minutes, sieved with 30 meshes for granulation, the granules and 2-3 parts by weight of magnesium stearate and 1-2 parts by weight of micro-powdered silica gel are mixed evenly, and pressed into tablets. It can disintegrate quickly in the oral cavity under anhydrous conditions (or only a small amount of water exists), enter the digestive tract with swallowing action, and have no mucosal absorption in the oral cavity. The absorption and metabolism process in the body are consistent with ordinary tablets. Compared with common preparations, it has the advantages of convenient administration, fast absorption, high bioavailability, and less irritation to the mucous membrane of the digestive tract.

Description

technical field [0001] The invention relates to the technical field of pharmaceutical preparations, in particular to an orally disintegrating itopride hydrochloride tablet and a preparation method thereof. Background technique [0002] The chemical name of itopride hydrochloride is N-[4-[2-(dimethylamino)ethoxy]benzyl]-3,4-dimethoxybenzamide hydrochloride. In my country, raw materials and tablets were accepted for clinical research in 2000, and capsules and tablets were accepted for clinical research in 2001. Among them, raw materials and tablets were protected as national second-class new drugs in 2001. Itopride hydrochloride is the main component of commonly used digestive system drugs and gastrointestinal motility drugs. Pharmacological effects of itopride hydrochloride: It has dual effects of dopamine D2 receptor blockade and acetylcholinesterase inhibition, enhances gastric and duodenal motility by stimulating the release of endogenous acetylcholine and inhibiting its...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K9/20A61K31/166A61K47/26A61K47/32A61P1/14A61P1/04A61P1/08
CPCA61K9/2018A61K9/0056A61K9/2027A61K31/166
Inventor 操铖高煜
Owner HUAYI PHARMA ANHUI CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products